{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:17:50Z","timestamp":1791980270411,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.beha.2010.07.003","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T09:28:13Z","timestamp":1281691693000},"page":"369-378","source":"Crossref","is-referenced-by-count":51,"title":["Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells"],"prefix":"10.1016","volume":"23","author":[{"given":"Peter","family":"Valent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Cerny-Reiterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Mirkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy I.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Sotlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2010.07.003_bib1","first-page":"5","article-title":"New insights into \u201cthe riddle of the mast cells\u201d: microenvironmental regulation of mast cell development and phenotypic heterogeneity","volume":"62","author":"Galli","year":"1990","journal-title":"Lab Invest"},{"key":"10.1016\/j.beha.2010.07.003_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0955-2235(91)90011-R","article-title":"The growth and differentiation of mast cells","volume":"3","author":"Valent","year":"1991","journal-title":"Prog Growth Factor Res"},{"key":"10.1016\/j.beha.2010.07.003_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199301283280408","article-title":"New concepts about the mast cell","volume":"328","author":"Galli","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2010.07.003_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni1158","article-title":"Mast cells in the development of adaptive immune responses","volume":"6","author":"Galli","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib5","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.148.3.772","article-title":"Effects of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells","volume":"148","author":"Kirshenbaum","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib7","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","article-title":"Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13)","volume":"94","author":"Kirshenbaum","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib8","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.4049\/jimmunol.151.8.4221","article-title":"Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly\u2212 CD14\u2212 CD17\u2212 colony forming cell","volume":"151","author":"Agis","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib9","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)\/kit ligand (KL) in long term culture","volume":"80","author":"Valent","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.90.2.735","article-title":"Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand","volume":"90","author":"Mitsui","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2010.07.003_bib11","first-page":"965","article-title":"The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others","volume":"142","author":"Galli","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2010.07.003_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0167-5699(94)90153-8","article-title":"The riddle of the mast cell: c-kit ligand as missing link?","volume":"15","author":"Valent","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.beha.2010.07.003_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(90)90304-W","article-title":"Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms","volume":"63","author":"Anderson","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.beha.2010.07.003_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1182\/blood.V85.3.641.bloodjournal853641","article-title":"Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form","volume":"85","author":"Miyazawa","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.190.2.267","article-title":"T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro","volume":"190","author":"Ochi","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2010.07.003_bib16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1398-9995.2005.00865.x","article-title":"Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors","volume":"60","author":"Schernthaner","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.beha.2010.07.003_bib17","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V73.7.1778.1778","article-title":"Mast cell typing: demonstration of a distinct hemopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes","volume":"73","author":"Valent","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60879-2","article-title":"Cell surface structures on human basophils and mast cells: biochemical and functional characterization","volume":"52","author":"Valent","year":"1992","journal-title":"Adv Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2567.1996.493578.x","article-title":"Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes","volume":"87","author":"Agis","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.beha.2010.07.003_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2332\/allergolint.55.173","article-title":"Gene expression profiling of human mast cell subtypes: an in silico study","volume":"55","author":"Saito","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.beha.2010.07.003_bib21","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implication","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib22","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood.V98.13.3784","article-title":"Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells","volume":"98","author":"Schernthaner","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2010.07.003_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/hupa.2001.24319","article-title":"Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117\/Kit, and bcl-xL","volume":"32","author":"Jordan","year":"2001","journal-title":"Human Pathol"},{"key":"10.1016\/j.beha.2010.07.003_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-065X.2001.790108.x","article-title":"Variable expression of activation-linked surface antigens on human mast cells in health and disease","volume":"179","author":"Valent","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.beha.2010.07.003_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000235115","article-title":"Further characterization of surface membrane structures expressed on human basophils and mast cells","volume":"91","author":"Valent","year":"1990","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib27","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1073\/pnas.88.8.3339","article-title":"Interleukin 4 promotes expression of mast cell ICAM-1 antigen","volume":"88","author":"Valent","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2010.07.003_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF01715119","article-title":"Differential expression of cell surface integrins on human mast cells and human basophils","volume":"65","author":"Sperr","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2010.07.003_bib29","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.155.6.3152","article-title":"Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88\/C5aR expression on skin mast cells","volume":"155","author":"F\u00fcreder","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/039463200702000301","article-title":"Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense","volume":"20","author":"Mayerhofer","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.beha.2010.07.003_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000053802","article-title":"Are mast cells masters in HIV-1 infection?","volume":"125","author":"Marone","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib32","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.4049\/jimmunol.172.7.4391","article-title":"Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells","volume":"172","author":"Sundstrom","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000087640","article-title":"Chemokine receptor expression by mast cells","volume":"87","author":"Juremalm","year":"2005","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.beha.2010.07.003_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000057747","article-title":"Detection of novel CD antigens on the surface of human mast cells and basophils","volume":"127","author":"Ghannadan","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1529-0131(199802)41:2<233::AID-ART7>3.0.CO;2-V","article-title":"Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis","volume":"41","author":"Kiener","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.beha.2010.07.003_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.iy.07.040189.000423","article-title":"Heterogeneity of mast cells and phenotypic change between subpopulations","volume":"7","author":"Kitamura","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib37","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.4049\/jimmunol.151.6.3206","article-title":"Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10","volume":"151","author":"Ghildyal","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib38","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.160.11.5537","article-title":"Reversible expression of tryptases and chymases in the jejunal mast cells of mice infected with Trichinella spiralis","volume":"160","author":"Friend","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0145-2126(01)00030-3","article-title":"Mast cell lineage development and phenotypic regulation","volume":"25","author":"Austen","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2010.07.003_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/039463200802100404","article-title":"CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking","volume":"21","author":"Hauswirth","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.beha.2010.07.003_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2010.07.003_bib42","first-page":"291","article-title":"Mastocytosis (mast cell disease). World Health Organization (WHO) classification of tumours. Pathology & Genetics","volume":"vol. 1","author":"Valent","year":"2001"},{"key":"10.1016\/j.beha.2010.07.003_bib43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","article-title":"Mast cell proliferative disorders: current view on variants recognized by the World Health Organization","volume":"17","author":"Valent","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.beha.2010.07.003_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.beha.2010.07.003_bib45","first-page":"54","article-title":"Mastocytosis (mast cell disease). World Health Organization (WHO) classification of tumours. Pathology & Genetics","volume":"vol. 2","author":"Horny","year":"2008"},{"key":"10.1016\/j.beha.2010.07.003_bib46","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.pas.0000138181.89743.7b","article-title":"CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens","volume":"28","author":"Sotlar","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2010.07.003_bib47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1309\/CX45R79PCU9HCV6V","article-title":"Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia","volume":"124","author":"Krokowski","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beha.2010.07.003_bib48","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2010.07.003_bib49","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/jcp.2005.029215","article-title":"Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7","volume":"59","author":"Agis","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.beha.2010.07.003_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jcp.2005.028738","article-title":"The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers","volume":"59","author":"Horny","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.beha.2010.07.003_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.thj.6200164","article-title":"Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells","volume":"3","author":"Valent","year":"2002","journal-title":"Hematol J"},{"key":"10.1016\/j.beha.2010.07.003_bib52","unstructured":"Arredondo AR, Gotlib J, Shier L, et-al. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Am J Hematol, (in press)."},{"key":"10.1016\/j.beha.2010.07.003_bib53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes","volume":"125","author":"Teodosio","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.beha.2010.07.003_bib54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0145-2126(03)00007-9","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of mast cell leukemia","volume":"27","author":"Drexler","year":"2003","journal-title":"Leukemia Res"},{"key":"10.1016\/j.beha.2010.07.003_bib55","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib56","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2141.2003.04125.x","article-title":"Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder","volume":"120","author":"Pardanani","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2010.07.003_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2009.01.001","article-title":"Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders","volume":"23","author":"Valent","year":"2009","journal-title":"Blood Rev"},{"issue":"S2","key":"10.1016\/j.beha.2010.07.003_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.0960-135X.2004.01369.x","article-title":"On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts","volume":"34","author":"Valent","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.beha.2010.07.003_bib60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.exphem.2006.09.008","article-title":"Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils","volume":"35","author":"Krauth","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.beha.2010.07.003_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10428190500272507","article-title":"Detection of molecular targets on the surface of CD34+\/CD38\u2212 stem cells in various myeloid malignancies","volume":"47","author":"Florian","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2010.07.003_bib62","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0301-472X(03)00112-7","article-title":"Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit","volume":"31","author":"Akin","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.beha.2010.07.003_bib63","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms","volume":"22","author":"Zermati","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2010.07.003_bib64","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","article-title":"PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects","volume":"107","author":"Gleixner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib65","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2004-12-4617","article-title":"Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412","volume":"106","author":"Growney","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib66","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","article-title":"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib67","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3324\/haematol.11339","article-title":"Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT","volume":"92","author":"Gleixner","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2010.07.003_bib68","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","article-title":"Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation","volume":"106","author":"Gotlib","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib69","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1600-0609.2008.01048.x","article-title":"Dasatinib therapy for systemic mastocytosis: four cases","volume":"80","author":"Purtill","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2010.07.003_bib70","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","article-title":"Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2010.07.003_bib71","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.leukres.2008.09.027","article-title":"Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V","volume":"33","author":"Ustun","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2010.07.003_bib72","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2362.2008.02036.x","article-title":"Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis","volume":"38","author":"Aichberger","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.beha.2010.07.003_bib73","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1200\/JCO.2001.19.13.3244","article-title":"Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse","volume":"19","author":"Sievers","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2010.07.003_bib74","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/10428190500126075","article-title":"CD33 as a target of therapy in acute myeloid leukemia: current status and future perspectives","volume":"46","author":"Sperr","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2010.07.003_bib75","first-page":"959","article-title":"Immunization against tumor cell surface complement-regulatory proteins","volume":"2","author":"Durrant","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.beha.2010.07.003_bib76","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1523-1747.2002.00171.x","article-title":"Selection of mimotopes of the cell surface adhesion molecule Mel-CAM from a random pVIII-28aa phage peptide library","volume":"119","author":"Hafner","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.beha.2010.07.003_bib77","first-page":"3629","article-title":"Epitope-specific antibody response to HT-1080 fibrosarcoma cells by mimotope immunization","volume":"6","author":"Popkov","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2010.07.003_bib78","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2141.2003.04055.x","article-title":"Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis","volume":"120","author":"Nunez-Lopez","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2010.07.003_bib79","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2010.07.003_bib80","first-page":"658","article-title":"Smoldering systemic mastocytosis: successful therapy with cladribine","volume":"55","author":"Schleyer","year":"2004","journal-title":"Hautarzt"},{"key":"10.1016\/j.beha.2010.07.003_bib81","first-page":"2343","article-title":"The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multi- and unipotent progenitors","volume":"94","author":"B\u00fchring","year":"1999","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169261000040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169261000040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T20:08:24Z","timestamp":1685736504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169261000040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S152169261000040X"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2010.07.003","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}